Status:
WITHDRAWN
Using the Digital EEG Spectral Analysis in Assessing Neuroelectrical Processing Abnormalities in Autism
Lead Sponsor:
Yellen & Associates, Inc.
Conditions:
Autistic Disorder
Autism, Early Infantile
Eligibility:
All Genders
5-25 years
Brief Summary
Individuals with Autism Spectrum Disorder will have abnormal DESA® results. Our objective is to use neuroelectrical measures to determine the degree of processing abnormalities in individuals with Aut...
Detailed Description
The research method will be: gathering, analyzing and utilizing data. We will observe research subjects through neuroelectrical instrumentation, then, compare results to retrospective information col...
Eligibility Criteria
Inclusion
- The study will include children between the ages of five and eighteen, adults from the age of nineteen to twenty-five, and those with the diagnosis of Autism and Autism Spectrum Disorders.
Exclusion
- those with mental retardation
- those with any other neurological disorder
- those that cannot sit in a chair for one hundred and fifty minutes
- those that have been previously diagnosed with a seizure disorder
- those who are blind and/or deaf
- those who are not ambulatory
- those who cannot understand English
- those that are not a resident of Los Angeles County
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2012
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00693953
Start Date
January 1 2010
End Date
December 1 2012
Last Update
October 2 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yellen & Associates, Inc.
Northridge, California, United States, 91326